This hypothesis is supported by evidence showing that the Nrf2 inducer Tecfidera, inhibited the IL-6 and IL-1 gene expression in experimental models of multiple sclerosis and other autoimmune diseases [146,147,148,149]. Here, NFE2L2 is linked to multiple sclerosis.